Page 2 - Carnot

Improving Scientific expertise:
438 research staff and 29 research laboratories
knowledge, 18 technology platforms:
«Data science, transgenesis (CRISPR-Cas9), iPS

diagnosis and cells, biobank, histology, translational genetics,
genomics, single cell and tissue transcriptomics,
cytometry, animal facilities, gene transfer, AAV
treatment of vectors, cell imaging, proteomics, bioinformatics,
3T MRI, electrophysiology, neuro-behaviour

genetic diseases 6 integrated research and care programmes:
Immunology / Infectious Diseases /

by involving all Gastroenterology, Haematology, Nephrology,
Neurodevelopment, Cardiology and
Development, Translational Bioinformatics
relevant actors

Achievements

Institut Hospitalo-Universitaire since 2011

806 articles, 75 reviews and 46 scientific letters
A pipeline of more than 400 therapeutic and
diagnostic solutions, 30% of which come from the
laboratories and clinical units of institute Carnot
Imagine.
98 active patent families

Imagine Bioentrepreneurs Launchpad programme
in partnership with HEC, École Polytechnique and
Université Paris Cité

Coordination of the «Gene Therapy» DIM
(Domaine d’Intérêt Majeur) of the Île-de-France
Region 2017–2020
Housing of biotechnology companies

A translational research

institute dedicated to genetic
diseases Markets addressed
Pharmaceuticals, Biotechnology
Clinical expertise: Gene and cell therapies
510 health professionals, 8 clinical units, 31 Rare Diagnostics
Disease Reference Centres (with more than 35
000 medical consultations per year), 2 Clinical Medical devices and e-Health
Investigation Centres, a data warehouse and one
of the largest biobanks of genetic disease samples
in Europe.